Results 191 to 200 of about 37,118 (221)

Assessing the Effectiveness of a Short Injectable Treatment Regimen for Multidrug-Resistant Tuberculosis: Clinical Outcomes in Khyber Pakhtunkhwa. [PDF]

Cureus
Umar M, Basit A, Ali S, Iqbal Z, Jan F.
europepmc   +1 more source

Identifying risk factors for recurrent multidrug resistant tuberculosis based on patient's record data from 2016 to 2021: retrospective study. [PDF]

Sci Rep
Wotale TW, Lelisho ME, Negasa BW, Tareke SA, Gobena WE, Amesa EG.   +5 more
europepmc   +1 more source

Discovery and Biosynthesis of Persiathiacins: Unusual Polyglycosylated Thiopeptides Active Against Multidrug Resistant Tuberculosis. [PDF]

ACS Infect Dis
Dashti Y, Mohammadipanah F, Zhang Y, Cerqueira Diaz PM, Vocat A, Zabala D, Fage CD, Romero-Canelon I, Bunk B, Spröer C, Alkhalaf LM, Overmann J, Cole ST, Challis GL.   +13 more
europepmc   +1 more source

Safety and Effectiveness of 3 Novel All-Oral Shortened Regimens for Rifampicin- or Multidrug-Resistant Tuberculosis in Kazakhstan. [PDF]

Clin Infect Dis
Rashitov M, Franke MF, Trevisi L, Bekbolatova G, Shalimova J, Eshmetov G, Bektasov S, LaHood A, Arlyapova N, Osso E, Yedilbayev A, Korotych O, Ciobanu A, Skrahina A, Mitnick CD, Seung KJ, Algozhin Y, Rich ML.   +17 more
europepmc   +1 more source

Multidrug resistant tuberculosis and HIV coinfection : a study about a case and litterature review

, 2004
Sébastien Martin
openalex   +1 more source

Treatment outcomes and associated factors among patients with multidrug-resistant tuberculosis in Southwestern Oromia, Ethiopia: ten-year retrospective analysis. [PDF]

BMC Infect Dis
Bonsa Z, Tadesse M, Bekele E, Abeba G, Solomon E, Husen M, Balay G, Kebede W, Abebe G.   +8 more
europepmc   +1 more source

Examining the challenges in sustaining user engagement with a mobile app to enhance multidrug-resistant tuberculosis (MDR-TB) care in Vietnam and its implications for implementing person-centred mHealth interventions. [PDF]

PLOS Glob Public Health
Drabarek D, Trinh-Hoang D, Yapa M, Dang TTH, Vu HD, Nguyen TA, Do TT, Nguyen BH, Vu DH, Fox GJ, Bernays S.   +10 more
europepmc   +1 more source

Detection of extensive drug resistance by the Xpert MTB/XDR assay in multidrug resistant tuberculosis cases at a tertiary care centre in northern India, and therapeutic decision making for the six-month BPaLM regimen. [PDF]

J Clin Tuberc Other Mycobact Dis
Misra R, Das P, Nath A, Neyaz Z.
europepmc   +1 more source

Evaluation of extracts from used Xpert MTB/RIF cartridges for detection of resistance to second-line anti-tuberculosis drugs in patients with multidrug-resistant tuberculosis in Ethiopia. [PDF]

BMC Microbiol
Ketema T, Tadesse M, Bonsa Z, Balay G, Kebede W, Mekonnen M, Abebe G.   +6 more
europepmc   +1 more source